Expert consensus on electronic patient-reported outcome-based symptom management for perioperative lung cancer patients (version 2026)_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

DAI Wei ¹ , LEI Cheng ¹ , ZHANG Yuanqiang ² , ZHANG Rong ³ , JING Pengyu ⁴ , XU Jinming ⁵ , ZHENG Yuzhen ⁶ , ZHAO Liang ⁷ , QIAO Guibin ⁶ , CHE Guowei ^8,9 , HU Jian ⁵ , JIANG Lei ¹⁰ , LI Jie ¹¹ ,  LI Qiang ¹ ,  SHI Qiuling ^1,12 , Cardiothoracic Surgery Committee of Sichuan Medical Association , Sports-Medicine Integration and Non-Medical Health Intervention Committee of Sichuan Medical Association , Thoracic Minimally Invasive Surgery Committee of Integrated Traditional Chinese and Western Medicine, Shanghai Traditional Medicine Engineering Association , China Special Interest Group of the International Society for Quality of Life Research

1. Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, P. R. China;
2. Department of Cardiothoracic Surgery, Zigong First People's Hospital, Zigong, 643000, Sichuan, P. R. China;
3. Department of Thoracic Surgery, Ya'an People's Hospital, Ya'an, 625000, Sichuan, P. R. China;
4. Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, P. R. China;
5. Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, P. R. China;
6. Department of Thoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, P. R. China;
7. Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China;
8. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
9. Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, 611130, P. R. China;
10. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Shanghai, 200433, P. R. China;
11. Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, P. R. China;
12. School of Public Health, Chongqing Medical University, Chongqing, 400016, P. R. China;

Corresponding?author：

LI Qiang, Email: liqiang@sichuancancer.org; SHI Qiuling, Email: qshi@cqmu.edu.cn

Keywords：

Lung cancer; perioperative period; symptom management; electronic patient-reported outcome; expert consensus

DOI：

10.7507/1007-4848.202602074

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Patients with lung cancer experience a heavy symptom burden during the perioperative period, which seriously affects their recovery and quality of life. Traditional symptom management models rely mainly on scheduled ward rounds during hospitalization and outpatient follow-up after discharge. However, they have limitations such as delayed symptom recognition, lack of post-discharge monitoring, and non-quantitative symptom assessment, which often lead to delayed interventions and low patient satisfaction. In recent years, the symptom management model based on electronic patient-reported outcomes (ePRO) has been increasingly valued in clinical practice. Existing high-level evidence from both domestic and international studies indicates that, through proactive monitoring, real-time alerts, and remote interventions, this model enables dynamic and continuous symptom management and helps improve patient recovery and healthcare experience. As a supplement to routine medical care, the ePRO-based symptom management model aims to enhance the quality of care rather than replace existing medical processes. To promote the standardized application of this model in perioperative lung cancer care, this consensus integrates domestic and international evidence. After multiple rounds of voting by more than 50 experts, it formulates 12 consensus statements covering the three core components, symptom monitoring, alerting, and intervention, to provide scientific and practical recommendations for clinical practice.

1.	Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
2.	Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
3.	Shi JF, Wang L, Wu N, et al. Clinical characteristics and medical service utilization of lung cancer in China, 2005-2014: overall design and results from a multicenter retrospective epidemiologic survey. Lung Cancer, 2019, 128: 91-100.
4.	王成弟, 陳勃江, 宋璐佳, 等. 23228 例肺癌患者臨床流行病學及病理特征趨勢分析. 華西醫學, 2020, 35(7): 813-820.Wang CD, Chen BJ, Song LJ, et al. Epidemiological and pathological distribution characteristics in 23228 lung cancer patients. West China Med J, 2020, 35(7): 813-820.
5.	邵茜茜, 劉東英. 肺癌患者肺葉切除術后癥狀群調查研究. 護理學報, 2018, 25(18): 1-4.Shao XX, Liu DY. Symptom cluster of lung cancer patients after lobectomy. J Nurs, 2018, 25(18): 1-4.
6.	Hirpara DH, Coburn NG, Darling GE, et al. Symptom assessment following surgery for lung cancer: a Canadian population-based retrospective cohort study. Ann Surg, 2023, 277(2): e428-e438.
7.	Tang L, Yu H, Dai W, et al. Symptom trajectories informing patient care after lung cancer surgery: a longitudinal patient-reported outcome study. Ann Surg Oncol, 2023, 30(5): 2607-2617.
8.	Fagundes CP, Shi Q, Vaporciyan AA, et al. Symptom recovery after thoracic surgery: measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg, 2015, 150(3): 613-619. e2.
9.	Zhang J, Su X, Xu W, et al. Identifying patients who suffered from post-discharge cough after lung cancer surgery. Support Care Cancer, 2022, 30(9): 7705-7713.
10.	Hopkins KG, Hoffman LA, Dabbs Ade V, et al. Postthoracotomy pain syndrome following surgery for lung cancer: symptoms and impact on quality of life. J Adv Pract Oncol, 2015, 6(2): 121-132.
11.	戴維, 石丘玲, 李強, 等. 基于患者報告結局的癥狀管理在肺癌外科的應用現狀. 中國胸心血管外科臨床雜志, 2020, 27(10): 1228-1234.Dai W, Shi QL, Li Q, et al. Current application of patient-reported outcome-based symptom management in lung cancer surgery. Chin J Clin Thorac Cardiovasc Surg, 2020, 27(10): 1228-1234.
12.	Liu Y, Li S, Yu J, et al. Demand analysis of transitional care for patients undergoing minimally invasive cardiac interventions with AI-driven solutions: a mixed-methods approach. BMC Nurs, 2025, 24(1): 453.
13.	King M, Kerr A, Dixon S, et al. Multicentre review of readmission rates within 30 days of discharge following lung cancer surgery. Br J Nurs, 2019, 28(17): S16-S22.
14.	Quero-Valenzuela F, Piedra-Fernández I, Martínez-Ceres M, et al. Predictors for 30-day readmission after pulmonary resection for lung cancer. J Surg Oncol, 2018, 117(6): 1239-1245.
15.	宋君. 肺癌患者術后護理中的優質護理服務分析. 中國衛生標準管理, 2017, 8(17): 162-164.Song J. Analysis of high quality nursing service in postoperative nursing care of patients with lung cancer. China Health Stand Manag, 2017, 8(17): 162-164.
16.	張文惠. 心理護理對肺癌手術患者不良情緒和滿意度的影響評價. 黑龍江中醫藥, 2021, 50(2): 373-374.Zhang WH. Evaluation of the effect of psychological nursing on negative emotions and satisfaction of lung cancer surgery patients. Heilongjiang J Tradit Chin Med, 2021, 50(2): 373-374.
17.	Basch E. Patient-reported outcomes - Harnessing patients' voices to improve clinical care. N Engl J Med, 2017, 376(2): 105-108.
18.	Pompili C, Basch E, Velikova G, et al. Electronic patient-reported outcomes after thoracic surgery: toward better remote management of perioperative symptoms. Ann Surg Oncol, 2021, 28(4): 1878-1879.
19.	Gomes Siqueira LBM, Callens D, Choi S, et al. Implementation of electronic patient-reported outcomes in supportive care for oncology patients. Curr Opin Support Palliat Care, 2026, 20(1): 24-32.
20.	國家腫瘤質控中心乳腺癌專家委員會, 中國抗癌協會乳腺癌專業委員會, 中國抗癌協會腫瘤藥物臨床研究專業委員會. 中國晚期乳腺癌規范診療指南(2024版). 中華腫瘤雜志, 2024, 46(12): 1079-1106.Breast Cancer Expert Committee of National Cancer Quality Control Center, Breast Cancer Expert Committee of China Anti-Cancer Association, Cancer Drug Clinical Research Committee of China Anti-Cancer Association. Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition). Chin J Oncol, 2024, 46(12): 1079-1106.
21.	中國醫師協會腫瘤醫師分會, 中國抗癌協會腫瘤營養專業委員會. 基于患者報告結局的腫瘤營養治療系統臨床應用專家共識. 腫瘤代謝與營養電子雜志, 2024, 11(2): 169-180.Chinese Association for Clinical Oncologists, Chinese Society of Nutritional Oncology. Expert consensus on clinical application of nutritional oncology therapy system based on patient-reported outcome. Electron J Metab Nutr Cancer, 2024, 11(2): 169-180.
22.	劉倫旭, 高樹庚, 何建行, 等. 非小細胞肺癌術后隨訪中國胸外科專家共識(2025版). 中國胸心血管外科臨床雜志, 2025, 32(3): 281-290.Liu LX, Gao SG, He JX, et al. Chinese expert consensus on postoperative follow-up for non-small cell lung cancer (version 2025). Chin J Clin Thorac Cardiovasc Surg, 2025, 32(3): 281-290.
23.	Di Maio M, Basch E, Denis F, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Ann Oncol, 2022, 33(9): 878-892.
24.	U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes, 2006, 4: 79.
25.	Dai W, Chang S, Pompili C, et al. Early postoperative patient-reported outcomes after thoracoscopic segmentectomy versus lobectomy for small-sized peripheral non-small-cell lung cancer. Ann Surg Oncol, 2022, 29(1): 547-556.
26.	Dai W, Dai Z, Wei X, et al. Early patient-reported outcomes after uniportal vs multiportal thoracoscopic lobectomy. Ann Thorac Surg, 2022, 114(4): 1229-1237.
27.	Zhang K, Liu W, Zhao Y, et al. Comparison of early postoperative patient-reported outcomes after multiportal robotic-assisted thoracoscopic surgery and uniportal video-assisted thoracoscopic surgery for non-small cell lung cancer. Eur J Surg Oncol, 2024, 50(9): 108481.
28.	Cleeland CS, Wang XS, Shi Q, et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol, 2011, 29(8): 994-1000.
29.	Dai W, Feng W, Zhang Y, et al. Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial. J Clin Oncol, 2022, 40(9): 988-996.
30.	Dai W, Wang Y, Liao J, et al. Electronic patient-reported outcome-based symptom management versus usual care after lung cancer surgery: long-term results of a multicenter, randomized, controlled trial. J Clin Oncol, 2024, 42(18): 2126-2131.
31.	Khullar OV, Perez A, Dixon M, et al. Routine implementation of patient-reported outcomes assessment into thoracic surgery practice. Ann Thorac Surg, 2023, 115(2): 526-532.
32.	Narra LR, Verdini N, Lapen K, et al. Patient-reported outcomes in clinical trials: from an endpoint to an intervention in cancer care. Semin Radiat Oncol, 2023, 33(4): 358-366.
33.	Li Y, Li J, Hu X. The effectiveness of symptom management interventions based on electronic patient-reported outcomes (ePROs) for symptom burden, quality of life, and overall survival among patients with cancer: a meta-analysis of randomized controlled trials. Int J Nurs Stud, 2023, 147: 104588.
34.	Lizán L, Pérez-Carbonell L, Comellas M. Additional value of patient-reported symptom monitoring in cancer care: a systematic review of the literature. Cancers (Basel), 2021, 13(18): 4615.
35.	Absolom K, Warrington L, Hudson E, et al. Phase Ⅲ randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. J Clin Oncol, 2021, 39(7): 734-747.
36.	Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol, 2016, 34(6): 557-565.
37.	Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 2017, 318(2): 197-198.
38.	Xu J, Ni H, Zhan H, et al. Efficacy of digital therapeutics for perioperative management in patients with lung cancer: a randomized controlled trial. BMC Med, 2025, 23(1): 186.
39.	Jing P, Liang Y, Tan Z, et al. Physiological and psychological symptom management based on electronic patient-reported outcomes: the TD-WELLBEING randomized clinical trial. Br J Cancer, 2025, 133(7): 937-944.
40.	盧羿同, 孫雨馨, 孟繁茂, 等. 基于患者報告結局的肺癌患者管理研究熱點及趨勢可視化分析. 中國胸心血管外科臨床雜志, 2025(9): 1318-1327.Lu YT, Sun YX, Meng FM, et al. Visual analysis of research hotspots and trends related to lung cancer patient management based on patient-reported outcomes. Chin J Clin Thorac Cardiovasc Surg, 2025(9): 1318-1327.
41.	European Medicines Agency. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man-the use of patient-reported outcome (PRO) measures in oncology studies: scientific guideline. 2016.
42.	Abola RE, Bennett-Guerrero E, Kent ML, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative joint consensus statement on patient-reported outcomes in an enhanced recovery pathway. Anesth Analg, 2018, 126(6): 1874-1882.
43.	Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO Extension. JAMA, 2018, 319(5): 483-494.
44.	Chan EKH, Edwards C, Haywood K, et al. Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user's guide. Qual Life Res, 2019, 28(3): 621-627.
45.	Cruz Rivera S, Aiyegbusi OL, Ives J, et al. Ethical considerations for the inclusion of patient-reported outcomes in clinical research: the PRO Ethics Guidelines. JAMA, 2022, 327(19): 1910-1919.
46.	Gagnier JJ, Lai J, Mokkink LB, et al. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res, 2021, 30(8): 2197-2218.
47.	Ramsey I, Corsini N, Hutchinson AD, et al. A core set of patient-reported outcomes for population-based cancer survivorship research: a consensus study. J Cancer Surviv, 2021, 15(2): 201-212.
48.	Snyder CF, Aaronson NK, Choucair AK, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res, 2012, 21(8): 1305-1314.
49.	Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017, 358: j4008.
50.	Wang Y, Keitz S, Briel M, et al. Development of ROBUST-RCT: risk of bias instrument for use in systematic reviews for randomised controlled trials. BMJ, 2025, 388: e081199.
51.	Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
52.	胡堅, 支修益, 劉倫旭, 等. 直徑≤2 cm肺結節胸外科合理診療中國專家共識(2024). 中國胸心血管外科臨床雜志, 2024, 31(8): 1077-1089.Hu J, Zhi XY, Liu LX, et al. Chinese thoracic surgery expert consensus on rational diagnosis and treatment of pulmonary nodules with a diameter ≤2 cm (2024). Chin J Clin Thorac Cardiovasc Surg, 2024, 31(8): 1077-1089.
53.	Yu H, Lei C, Wei X, et al. Electronic symptom monitoring after lung cancer surgery: establishing a core set of patient-reported outcomes for surgical oncology care in a longitudinal cohort study. Int J Surg, 2024, 110(10): 6591-6600.
54.	Lei C, Gong R, Zhang J, et al. Pain experience of lung cancer patients during home recovery after surgery: a qualitative descriptive study. Cancer Med, 2023, 12(19): 20212-20223.
55.	毛瑩穎, 丁君蓉, 胡穎燕, 等. 肺癌患者圍手術期癥狀管理體驗和需求的質性研究. 中華現代護理雜志, 2024, 30(7): 893-899.Mao YY, Ding JR, Hu YY, et al. Qualitative study on the experience and needs of perioperative symptom management in lung cancer patients. Chin J Mod Nurs, 2024, 30(7): 893-899.
56.	Merlo A, Carlson R, Espey J 3rd, et al. Postoperative symptom burden in patients undergoing lung cancer surgery. J Pain Symptom Manage, 2022, 64(3): 254-267.
57.	Basch E, Mody GN, Dueck AC. Electronic patient-reported outcomes as digital therapeutics to improve cancer outcomes. JCO Oncol Pract, 2020, 16(9): 541-542.
58.	Liang Y, Jing P, Gu Z, et al. Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol. Trials, 2024, 25(1): 130.
59.	Chan A, Ng D, Arcos D, et al. Electronic patient-reported outcome-driven symptom management by oncology pharmacists in a majority-minority population: an implementation study. JCO Oncol Pract, 2024: OP2400050.
60.	Crockett C, Price J, Pham M, et al. Experience with the routine use of electronic patient-reported outcome measures for patients with lung cancer. JCO Clin Cancer Inform, 2023, 7: e2200150.
61.	Salmani H, Nasiri S, Ahmadi M. The advantages, disadvantages, threats, and opportunities of electronic patient-reported outcome systems in cancer: a systematic review. Digit Health, 2024, 10: 20552076241257146.
62.	Sabatino MJ, Gans CV, Zynda AJ, et al. An electronic patient-reported outcomes measurement system in paediatric orthopaedics. J Child Orthop, 2019, 13(4): 431-437.
63.	Yu H, Yu Q, Nie Y, et al. Data quality of longitudinally collected patient-reported outcomes after thoracic surgery: comparison of paper- and web-based assessments. J Med Internet Res, 2021, 23(11): e28915.
64.	王松梅, 田暢, 岳林, 等. 移動醫療在癌痛延續護理中的應用進展. 中國護理管理, 2022, 22(8): 1238-1242.Wang SM, Tian C, Yue L, et al. Application of the mobile health in transitional care of cancer pain. Chin Nurs Manag, 2022, 22(8): 1238-1242.
65.	Boisson-Walsh A, Cox C, O'Leary M, et al. A qualitative study of electronic patient-reported outcome symptom monitoring after thoracic surgery. J Surg Res, 2024, 303: 744-755.
66.	Hsiao CJ, Dymek C, Kim B, et al. Advancing the use of patient-reported outcomes in practice: understanding challenges, opportunities, and the potential of health information technology. Qual Life Res, 2019, 28(6): 1575-1583.
67.	劉禎, 王紅, 張鳳霞. 數字健康技術在肺癌患者術后肺康復中的應用進展. 中國護理管理, 2025, 25(3): 471-475.Liu Z, Wang H, Zhang FX. Application progress on digital health technology in postoperative lung rehabilitation of lung cancer patients. Chin Nurs Manag, 2025, 25(3): 471-475.
68.	Riedl D, Lehmann J, Rothmund M, et al. Usability of electronic patient-reported outcome measures for older patients with cancer: secondary analysis of data from an observational single center study. J Med Internet Res, 2023, 25: e49476.
69.	Basch E, Schrag D, Henson S, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA, 2022, 327(24): 2413-2422.
70.	肖益萍. 肺癌患者圍手術期癥狀群的縱向研究. 河南, 新鄉醫學院, 2016.Xiao YP. Lung cancer patients' perioperative symptom clusters of longitudinal study. Henan, Xinxiang Medical University, 2016.
71.	張崎, 戴維, 魏星, 等. 患者報告結局量表在肺癌外科中的應用現狀. 中國胸心血管外科臨床雜志, 2024, 31(4): 606-612.Zhang Q, Dai W, Wei X, et al. Current application of patient-reported outcome measures in lung cancer surgery. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(4): 606-612.
72.	石丘玲, 王旭. 基于患者報告結局的癥狀監測在藥物警戒中的應用前景及方法學考量. 中國醫藥導刊, 2023, 25(12): 1194-1199.Shi QL, Wang X. Prospects and methodological considerations of PRO-based symptom monitoring for pharmacovigilance. Chin J Med Guide, 2023, 25(12): 1194-1199.
73.	龔若?, 冷虹瑤, 余鴻凡, 等. 不同評估方法在肺切除術患者圍手術期疼痛測量中的心理測量學特征. 陸軍軍醫大學學報, 2023, 45(20): 2132-2140.Gong RY, Leng HY, Yu HF, et al. Psychometric properties of different pain measuring scales in patients during perioperative period of lung resection. J Army Med Univ, 2023, 45(20): 2132-2140.
74.	Su X, Huang Y, Gong R, et al. Undergoing Lung Surgery (PSA-Lung) was appropriate for symptom assessment after discharge. Qual Life Res, 2024, 33(7): 1807-1818.
75.	Kim HJ, Jung SO. Comparative evaluations of single-item pain-intensity measures in cancer patients: numeric rating scale vs. verbal rating scale. J Clin Nurs, 2020, 29(15-16): 2945-2952.
76.	Atisook R, Euasobhon P, Saengsanon A, Jensen MP. Validity and utility of four pain intensity measures for use in international research. J Pain Res, 2021, 14: 1129-1139.
77.	Mendoza TR, Wang XS, Lu C, et al. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist, 2011, 16(2): 217-227.
78.	張立力, 臧瑜. MD安德森癥狀評估量表肺癌模塊的修訂和考評. 腫瘤, 2013, 33(5): 434-438.Zhang LL, Zang Y. Revision and evaluation of the lung cancer module of the MD Anderson Symptom Inventory. Tumor, 2013, 33(5): 434-438.
79.	王明銘, 李霞, 車國衛, 等. 肺癌患者術后癥狀評估量表的有效性及臨床應用. 中國胸心血管外科臨床雜志, 2017, 24(6): 417-422.Wang MM, Li X, Che GW, et al. Validity and clinical application of postoperative symptom assessment scale in lung cancer patients. Chin J Clin Thorac Cardiovasc Surg, 2017, 24(6): 417-422.
80.	Wei X, Yu H, Dai W, et al. Patient-reported outcomes of video-assisted thoracoscopic surgery versus thoracotomy for locally advanced lung cancer: a longitudinal cohort study. Ann Surg Oncol, 2021, 28(13): 8358-8371.
81.	Wei X, Yu H, King-Kallimanis B, et al. Long-term function recovery following upper versus lower lobectomy for lung cancer: a multicenter longitudinal cohort study. Thorac Cancer, 2025, 16(1): e15505.
82.	Avery KNL, Richards HS, Portal A, et al. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery. BMC Cancer, 2019, 19(1): 463.
83.	O'Leary MC, Kwong E, Cox C, et al. Patient motivators of postoperative electronic patient-reported outcome symptom monitoring use in thoracic surgery patients: a qualitative study. J Patient Rep Outcomes, 2024, 8(1): 81.
84.	Sewell M, Boerner T, Harrington C, et al. Remote symptom monitoring in thoracic surgery patients after discharge. Ann Surg, 2025, 281(6): 1063-1069.
85.	Huang L, Kehlet H, Petersen RH. Reasons for staying in hospital after video-assisted thoracoscopic surgery lobectomy. BJS Open, 2022, 6(3): zrac050.
86.	Shahoud J, Weksler B, Williams B, et al. Uniportal video-assisted lung resection versus robotic-assisted lung resection, is there a difference? J Thorac Dis, 2024, 16(11): 7539-7545.
87.	Diaz-Gutierrez I, Menier CA, Savoie-White FH, et al. Uniportal vs. multiportal thoracoscopic segmentectomy: a North American study. J Thorac Dis, 2023, 15(2): 335-347.
88.	洪子強, 茍文曦, 逯英杰, 等. 達芬奇機器人手術與胸腔鏡手術治療非小細胞肺癌的短期療效及成本分析. 中國胸心血管外科臨床雜志, 2024, 31(7): 974-979.Hong ZQ, Gou WX, Lu YJ, et al. Short-term efficacy and cost analysis of Da Vinci robot-assisted thoracic surgery versus video-assisted thoracoscopic surgery for non-small cell lung cancer. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(7): 974-979.
89.	李田, 王高祥, 徐世斌, 等. 單孔胸腔鏡肺段切除術治療早期非小細胞肺癌的臨床研究. 安徽醫科大學學報, 2021, 56(11): 1816-1819.Li T, Wang GX, Xu SB, et al. Clinical study of uniportal thoracoscopic segmentectomy in the treatment of early non-small cell lung cancer. Acta Univ Med Anhui, 2021, 56(11): 1816-1819.
90.	王雅琴, 余鴻凡, 戴維, 等. 肺癌患者圍手術期自我報告疼痛評分與臨床記錄的一致性分析. 中國胸心血管外科臨床雜志, 2023, 30(11): 1545-1550.Wang YQ, Yu HF, Dai W, et al. Consistency analysis between self-reported pain scores and clinical records in lung cancer patients during perioperative period. Chin J Clin Thorac Cardiovasc Surg, 2023, 30(11): 1545-1550.
91.	Wei X, Yu H, Dai W, et al. Discrepancy in the perception of symptoms among patients and healthcare providers after lung cancer surgery. Support Care Cancer, 2022, 30(2): 1169-1179.
92.	吳傳美, 周和玲, 蔣艷華, 等. 肺癌患者手術前自我報告癥狀負擔和生活質量的橫斷面調查. 腫瘤預防與治療, 2021, 34(3): 234-240.Wu CM, Zhou HL, Jiang YH, et al. A cross-sectional survey of self-reported symptom burden and quality of life in lung cancer patients before surgery. J Cancer Control Treat, 2021, 34(3): 234-240.
93.	周和玲, 蔣艷華, 吳傳美, 等. 肺癌病人術前苦惱現狀及其影響因素. 護理研究, 2021, 35(19): 3486-3489.Zhou HL, Jiang YH, Wu CM, et al. Current status and influencing factors of preoperative distress in lung cancer patients. Chin Nurs Res, 2021, 35(19): 3486-3489.
94.	Mooney KH, Beck SL, Friedman RH, et al. Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial. Support Care Cancer, 2014, 22(9): 2343-2350.
95.	Swarm RA, Paice JA, Anghelescu DL, et al. Adult cancer pain, version 3. 2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2019, 17(8): 977-1007.
96.	Riba MB, Donovan KA, Andersen B, et al. Distress management, version 3. 2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2019, 17(10): 1229-1249.
97.	Yu Q, Yu H, Xu W, et al. Shortness of breath on day 1 after surgery alerting the presence of early respiratory complications after surgery in lung cancer patients. Patient Prefer Adherence, 2022, 16: 709-722.
98.	Kang D, Lei C, Zhang Y, et al. Shortness of breath on the day of discharge: an early alert for post-discharge complications in patients undergoing lung cancer surgery. J Cardiothorac Surg, 2024, 19(1): 398.
99.	Maguire R, Fox PA, McCann L, et al. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer. BMJ Open, 2017, 7(5): e015016.
100.	Pusic AL, Temple LK, Carter J, et al. A randomized controlled trial evaluating electronic outpatient symptom monitoring after ambulatory cancer surgery. Ann Surg, 2021, 274(3): 441-448.
101.	Furlong E, Darley A, Fox P, et al. Adaptation and implementation of a mobile phone-based remote symptom monitoring system for people with cancer in Europe. JMIR Cancer, 2019, 5(1): e10813.
102.	Richards HS, Blazeby JM, Portal A, et al. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery. BMC Cancer, 2020, 20(1): 543.
103.	Maguire R, McCann L, Kotronoulas G, et al. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ, 2021, 374: n1647.
104.	Stabile C, Temple LK, Ancker JS, et al. Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: a randomised controlled trial protocol. BMJ Open, 2019, 9(9): e030863.
105.	Franzoi MA, Ferreira AR, Lemaire A, et al. Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium. Lancet Reg Health Eur, 2024, 44: 101005.
106.	Li Y, Shen L, Ding J, et al. Derivation and validation of a nomogram model for pulmonary thromboembolism in patients undergoing lung cancer surgery. Transl Lung Cancer Res, 2021, 10(4): 1829-1840.
107.	Zhou X, Lei C, Wei X, et al. Patient's experiences of coughing after lung cancer surgery: a multicenter qualitative study. Cancer Med, 2024, 13(2): e6993.
108.	Song HJ, Seo HJ, Choi EJ, et al. Nursing care services to address unmet supportive care needs among cancer survivors: a systematic review. J Cancer Surviv, 2026, 20(2): 427-452.
109.	Riba MB, Donovan KA, Ahmed K, et al. NCCN Guidelines? Insights: distress management, version 2. 2023. J Natl Compr Canc Netw, 2023, 21(5): 450-457.
110.	Bower JE, Lacchetti C, Alici Y, et al. Management of fatigue in adult survivors of cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol, 2024, 42(20): 2456-2487.
111.	肺癌圍術期疼痛管理專家共識編寫組, 國家呼吸醫學中心(廣州), 全國疼痛診療研究中心, 國家疼痛專業醫療質量控制中心. 肺癌圍術期疼痛管理專家共識(2026版). 中國胸心血管外科臨床雜志, 2026, 33(5): 659-673.Expert Consensus Group on Perioperative Pain Management for Lung Cancer, National Center for Respiratory Medicine (Guangzhou), National Research Center for Pain Diagnosis and Treatment, National Medical Quality Control Center for Pain Specialty. Expert consensus on perioperative pain management for lung cancer (2026 edition). Chin J Clin Thorac Cardiovasc Surg, 2026, 33(5): 659-673.

1. Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
3. Shi JF, Wang L, Wu N, et al. Clinical characteristics and medical service utilization of lung cancer in China, 2005-2014: overall design and results from a multicenter retrospective epidemiologic survey. Lung Cancer, 2019, 128: 91-100.
4. 王成弟, 陳勃江, 宋璐佳, 等. 23228 例肺癌患者臨床流行病學及病理特征趨勢分析. 華西醫學, 2020, 35(7): 813-820.Wang CD, Chen BJ, Song LJ, et al. Epidemiological and pathological distribution characteristics in 23228 lung cancer patients. West China Med J, 2020, 35(7): 813-820.
5. 邵茜茜, 劉東英. 肺癌患者肺葉切除術后癥狀群調查研究. 護理學報, 2018, 25(18): 1-4.Shao XX, Liu DY. Symptom cluster of lung cancer patients after lobectomy. J Nurs, 2018, 25(18): 1-4.
6. Hirpara DH, Coburn NG, Darling GE, et al. Symptom assessment following surgery for lung cancer: a Canadian population-based retrospective cohort study. Ann Surg, 2023, 277(2): e428-e438.
7. Tang L, Yu H, Dai W, et al. Symptom trajectories informing patient care after lung cancer surgery: a longitudinal patient-reported outcome study. Ann Surg Oncol, 2023, 30(5): 2607-2617.
8. Fagundes CP, Shi Q, Vaporciyan AA, et al. Symptom recovery after thoracic surgery: measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg, 2015, 150(3): 613-619. e2.
9. Zhang J, Su X, Xu W, et al. Identifying patients who suffered from post-discharge cough after lung cancer surgery. Support Care Cancer, 2022, 30(9): 7705-7713.
10. Hopkins KG, Hoffman LA, Dabbs Ade V, et al. Postthoracotomy pain syndrome following surgery for lung cancer: symptoms and impact on quality of life. J Adv Pract Oncol, 2015, 6(2): 121-132.
11. 戴維, 石丘玲, 李強, 等. 基于患者報告結局的癥狀管理在肺癌外科的應用現狀. 中國胸心血管外科臨床雜志, 2020, 27(10): 1228-1234.Dai W, Shi QL, Li Q, et al. Current application of patient-reported outcome-based symptom management in lung cancer surgery. Chin J Clin Thorac Cardiovasc Surg, 2020, 27(10): 1228-1234.
12. Liu Y, Li S, Yu J, et al. Demand analysis of transitional care for patients undergoing minimally invasive cardiac interventions with AI-driven solutions: a mixed-methods approach. BMC Nurs, 2025, 24(1): 453.
13. King M, Kerr A, Dixon S, et al. Multicentre review of readmission rates within 30 days of discharge following lung cancer surgery. Br J Nurs, 2019, 28(17): S16-S22.
14. Quero-Valenzuela F, Piedra-Fernández I, Martínez-Ceres M, et al. Predictors for 30-day readmission after pulmonary resection for lung cancer. J Surg Oncol, 2018, 117(6): 1239-1245.
15. 宋君. 肺癌患者術后護理中的優質護理服務分析. 中國衛生標準管理, 2017, 8(17): 162-164.Song J. Analysis of high quality nursing service in postoperative nursing care of patients with lung cancer. China Health Stand Manag, 2017, 8(17): 162-164.
16. 張文惠. 心理護理對肺癌手術患者不良情緒和滿意度的影響評價. 黑龍江中醫藥, 2021, 50(2): 373-374.Zhang WH. Evaluation of the effect of psychological nursing on negative emotions and satisfaction of lung cancer surgery patients. Heilongjiang J Tradit Chin Med, 2021, 50(2): 373-374.
17. Basch E. Patient-reported outcomes - Harnessing patients' voices to improve clinical care. N Engl J Med, 2017, 376(2): 105-108.
18. Pompili C, Basch E, Velikova G, et al. Electronic patient-reported outcomes after thoracic surgery: toward better remote management of perioperative symptoms. Ann Surg Oncol, 2021, 28(4): 1878-1879.
19. Gomes Siqueira LBM, Callens D, Choi S, et al. Implementation of electronic patient-reported outcomes in supportive care for oncology patients. Curr Opin Support Palliat Care, 2026, 20(1): 24-32.
20. 國家腫瘤質控中心乳腺癌專家委員會, 中國抗癌協會乳腺癌專業委員會, 中國抗癌協會腫瘤藥物臨床研究專業委員會. 中國晚期乳腺癌規范診療指南(2024版). 中華腫瘤雜志, 2024, 46(12): 1079-1106.Breast Cancer Expert Committee of National Cancer Quality Control Center, Breast Cancer Expert Committee of China Anti-Cancer Association, Cancer Drug Clinical Research Committee of China Anti-Cancer Association. Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition). Chin J Oncol, 2024, 46(12): 1079-1106.
21. 中國醫師協會腫瘤醫師分會, 中國抗癌協會腫瘤營養專業委員會. 基于患者報告結局的腫瘤營養治療系統臨床應用專家共識. 腫瘤代謝與營養電子雜志, 2024, 11(2): 169-180.Chinese Association for Clinical Oncologists, Chinese Society of Nutritional Oncology. Expert consensus on clinical application of nutritional oncology therapy system based on patient-reported outcome. Electron J Metab Nutr Cancer, 2024, 11(2): 169-180.
22. 劉倫旭, 高樹庚, 何建行, 等. 非小細胞肺癌術后隨訪中國胸外科專家共識(2025版). 中國胸心血管外科臨床雜志, 2025, 32(3): 281-290.Liu LX, Gao SG, He JX, et al. Chinese expert consensus on postoperative follow-up for non-small cell lung cancer (version 2025). Chin J Clin Thorac Cardiovasc Surg, 2025, 32(3): 281-290.
23. Di Maio M, Basch E, Denis F, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Ann Oncol, 2022, 33(9): 878-892.
24. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes, 2006, 4: 79.
25. Dai W, Chang S, Pompili C, et al. Early postoperative patient-reported outcomes after thoracoscopic segmentectomy versus lobectomy for small-sized peripheral non-small-cell lung cancer. Ann Surg Oncol, 2022, 29(1): 547-556.
26. Dai W, Dai Z, Wei X, et al. Early patient-reported outcomes after uniportal vs multiportal thoracoscopic lobectomy. Ann Thorac Surg, 2022, 114(4): 1229-1237.
27. Zhang K, Liu W, Zhao Y, et al. Comparison of early postoperative patient-reported outcomes after multiportal robotic-assisted thoracoscopic surgery and uniportal video-assisted thoracoscopic surgery for non-small cell lung cancer. Eur J Surg Oncol, 2024, 50(9): 108481.
28. Cleeland CS, Wang XS, Shi Q, et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol, 2011, 29(8): 994-1000.
29. Dai W, Feng W, Zhang Y, et al. Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: a multicenter randomized controlled trial. J Clin Oncol, 2022, 40(9): 988-996.
30. Dai W, Wang Y, Liao J, et al. Electronic patient-reported outcome-based symptom management versus usual care after lung cancer surgery: long-term results of a multicenter, randomized, controlled trial. J Clin Oncol, 2024, 42(18): 2126-2131.
31. Khullar OV, Perez A, Dixon M, et al. Routine implementation of patient-reported outcomes assessment into thoracic surgery practice. Ann Thorac Surg, 2023, 115(2): 526-532.
32. Narra LR, Verdini N, Lapen K, et al. Patient-reported outcomes in clinical trials: from an endpoint to an intervention in cancer care. Semin Radiat Oncol, 2023, 33(4): 358-366.
33. Li Y, Li J, Hu X. The effectiveness of symptom management interventions based on electronic patient-reported outcomes (ePROs) for symptom burden, quality of life, and overall survival among patients with cancer: a meta-analysis of randomized controlled trials. Int J Nurs Stud, 2023, 147: 104588.
34. Lizán L, Pérez-Carbonell L, Comellas M. Additional value of patient-reported symptom monitoring in cancer care: a systematic review of the literature. Cancers (Basel), 2021, 13(18): 4615.
35. Absolom K, Warrington L, Hudson E, et al. Phase Ⅲ randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. J Clin Oncol, 2021, 39(7): 734-747.
36. Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol, 2016, 34(6): 557-565.
37. Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 2017, 318(2): 197-198.
38. Xu J, Ni H, Zhan H, et al. Efficacy of digital therapeutics for perioperative management in patients with lung cancer: a randomized controlled trial. BMC Med, 2025, 23(1): 186.
39. Jing P, Liang Y, Tan Z, et al. Physiological and psychological symptom management based on electronic patient-reported outcomes: the TD-WELLBEING randomized clinical trial. Br J Cancer, 2025, 133(7): 937-944.
40. 盧羿同, 孫雨馨, 孟繁茂, 等. 基于患者報告結局的肺癌患者管理研究熱點及趨勢可視化分析. 中國胸心血管外科臨床雜志, 2025(9): 1318-1327.Lu YT, Sun YX, Meng FM, et al. Visual analysis of research hotspots and trends related to lung cancer patient management based on patient-reported outcomes. Chin J Clin Thorac Cardiovasc Surg, 2025(9): 1318-1327.
41. European Medicines Agency. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man-the use of patient-reported outcome (PRO) measures in oncology studies: scientific guideline. 2016.
42. Abola RE, Bennett-Guerrero E, Kent ML, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative joint consensus statement on patient-reported outcomes in an enhanced recovery pathway. Anesth Analg, 2018, 126(6): 1874-1882.
43. Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO Extension. JAMA, 2018, 319(5): 483-494.
44. Chan EKH, Edwards C, Haywood K, et al. Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user's guide. Qual Life Res, 2019, 28(3): 621-627.
45. Cruz Rivera S, Aiyegbusi OL, Ives J, et al. Ethical considerations for the inclusion of patient-reported outcomes in clinical research: the PRO Ethics Guidelines. JAMA, 2022, 327(19): 1910-1919.
46. Gagnier JJ, Lai J, Mokkink LB, et al. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res, 2021, 30(8): 2197-2218.
47. Ramsey I, Corsini N, Hutchinson AD, et al. A core set of patient-reported outcomes for population-based cancer survivorship research: a consensus study. J Cancer Surviv, 2021, 15(2): 201-212.
48. Snyder CF, Aaronson NK, Choucair AK, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res, 2012, 21(8): 1305-1314.
49. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017, 358: j4008.
50. Wang Y, Keitz S, Briel M, et al. Development of ROBUST-RCT: risk of bias instrument for use in systematic reviews for randomised controlled trials. BMJ, 2025, 388: e081199.
51. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
52. 胡堅, 支修益, 劉倫旭, 等. 直徑≤2 cm肺結節胸外科合理診療中國專家共識(2024). 中國胸心血管外科臨床雜志, 2024, 31(8): 1077-1089.Hu J, Zhi XY, Liu LX, et al. Chinese thoracic surgery expert consensus on rational diagnosis and treatment of pulmonary nodules with a diameter ≤2 cm (2024). Chin J Clin Thorac Cardiovasc Surg, 2024, 31(8): 1077-1089.
53. Yu H, Lei C, Wei X, et al. Electronic symptom monitoring after lung cancer surgery: establishing a core set of patient-reported outcomes for surgical oncology care in a longitudinal cohort study. Int J Surg, 2024, 110(10): 6591-6600.
54. Lei C, Gong R, Zhang J, et al. Pain experience of lung cancer patients during home recovery after surgery: a qualitative descriptive study. Cancer Med, 2023, 12(19): 20212-20223.
55. 毛瑩穎, 丁君蓉, 胡穎燕, 等. 肺癌患者圍手術期癥狀管理體驗和需求的質性研究. 中華現代護理雜志, 2024, 30(7): 893-899.Mao YY, Ding JR, Hu YY, et al. Qualitative study on the experience and needs of perioperative symptom management in lung cancer patients. Chin J Mod Nurs, 2024, 30(7): 893-899.
56. Merlo A, Carlson R, Espey J 3rd, et al. Postoperative symptom burden in patients undergoing lung cancer surgery. J Pain Symptom Manage, 2022, 64(3): 254-267.
57. Basch E, Mody GN, Dueck AC. Electronic patient-reported outcomes as digital therapeutics to improve cancer outcomes. JCO Oncol Pract, 2020, 16(9): 541-542.
58. Liang Y, Jing P, Gu Z, et al. Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol. Trials, 2024, 25(1): 130.
59. Chan A, Ng D, Arcos D, et al. Electronic patient-reported outcome-driven symptom management by oncology pharmacists in a majority-minority population: an implementation study. JCO Oncol Pract, 2024: OP2400050.
60. Crockett C, Price J, Pham M, et al. Experience with the routine use of electronic patient-reported outcome measures for patients with lung cancer. JCO Clin Cancer Inform, 2023, 7: e2200150.
61. Salmani H, Nasiri S, Ahmadi M. The advantages, disadvantages, threats, and opportunities of electronic patient-reported outcome systems in cancer: a systematic review. Digit Health, 2024, 10: 20552076241257146.
62. Sabatino MJ, Gans CV, Zynda AJ, et al. An electronic patient-reported outcomes measurement system in paediatric orthopaedics. J Child Orthop, 2019, 13(4): 431-437.
63. Yu H, Yu Q, Nie Y, et al. Data quality of longitudinally collected patient-reported outcomes after thoracic surgery: comparison of paper- and web-based assessments. J Med Internet Res, 2021, 23(11): e28915.
64. 王松梅, 田暢, 岳林, 等. 移動醫療在癌痛延續護理中的應用進展. 中國護理管理, 2022, 22(8): 1238-1242.Wang SM, Tian C, Yue L, et al. Application of the mobile health in transitional care of cancer pain. Chin Nurs Manag, 2022, 22(8): 1238-1242.
65. Boisson-Walsh A, Cox C, O'Leary M, et al. A qualitative study of electronic patient-reported outcome symptom monitoring after thoracic surgery. J Surg Res, 2024, 303: 744-755.
66. Hsiao CJ, Dymek C, Kim B, et al. Advancing the use of patient-reported outcomes in practice: understanding challenges, opportunities, and the potential of health information technology. Qual Life Res, 2019, 28(6): 1575-1583.
67. 劉禎, 王紅, 張鳳霞. 數字健康技術在肺癌患者術后肺康復中的應用進展. 中國護理管理, 2025, 25(3): 471-475.Liu Z, Wang H, Zhang FX. Application progress on digital health technology in postoperative lung rehabilitation of lung cancer patients. Chin Nurs Manag, 2025, 25(3): 471-475.
68. Riedl D, Lehmann J, Rothmund M, et al. Usability of electronic patient-reported outcome measures for older patients with cancer: secondary analysis of data from an observational single center study. J Med Internet Res, 2023, 25: e49476.
69. Basch E, Schrag D, Henson S, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA, 2022, 327(24): 2413-2422.
70. 肖益萍. 肺癌患者圍手術期癥狀群的縱向研究. 河南, 新鄉醫學院, 2016.Xiao YP. Lung cancer patients' perioperative symptom clusters of longitudinal study. Henan, Xinxiang Medical University, 2016.
71. 張崎, 戴維, 魏星, 等. 患者報告結局量表在肺癌外科中的應用現狀. 中國胸心血管外科臨床雜志, 2024, 31(4): 606-612.Zhang Q, Dai W, Wei X, et al. Current application of patient-reported outcome measures in lung cancer surgery. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(4): 606-612.
72. 石丘玲, 王旭. 基于患者報告結局的癥狀監測在藥物警戒中的應用前景及方法學考量. 中國醫藥導刊, 2023, 25(12): 1194-1199.Shi QL, Wang X. Prospects and methodological considerations of PRO-based symptom monitoring for pharmacovigilance. Chin J Med Guide, 2023, 25(12): 1194-1199.
73. 龔若?, 冷虹瑤, 余鴻凡, 等. 不同評估方法在肺切除術患者圍手術期疼痛測量中的心理測量學特征. 陸軍軍醫大學學報, 2023, 45(20): 2132-2140.Gong RY, Leng HY, Yu HF, et al. Psychometric properties of different pain measuring scales in patients during perioperative period of lung resection. J Army Med Univ, 2023, 45(20): 2132-2140.
74. Su X, Huang Y, Gong R, et al. Undergoing Lung Surgery (PSA-Lung) was appropriate for symptom assessment after discharge. Qual Life Res, 2024, 33(7): 1807-1818.
75. Kim HJ, Jung SO. Comparative evaluations of single-item pain-intensity measures in cancer patients: numeric rating scale vs. verbal rating scale. J Clin Nurs, 2020, 29(15-16): 2945-2952.
76. Atisook R, Euasobhon P, Saengsanon A, Jensen MP. Validity and utility of four pain intensity measures for use in international research. J Pain Res, 2021, 14: 1129-1139.
77. Mendoza TR, Wang XS, Lu C, et al. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist, 2011, 16(2): 217-227.
78. 張立力, 臧瑜. MD安德森癥狀評估量表肺癌模塊的修訂和考評. 腫瘤, 2013, 33(5): 434-438.Zhang LL, Zang Y. Revision and evaluation of the lung cancer module of the MD Anderson Symptom Inventory. Tumor, 2013, 33(5): 434-438.
79. 王明銘, 李霞, 車國衛, 等. 肺癌患者術后癥狀評估量表的有效性及臨床應用. 中國胸心血管外科臨床雜志, 2017, 24(6): 417-422.Wang MM, Li X, Che GW, et al. Validity and clinical application of postoperative symptom assessment scale in lung cancer patients. Chin J Clin Thorac Cardiovasc Surg, 2017, 24(6): 417-422.
80. Wei X, Yu H, Dai W, et al. Patient-reported outcomes of video-assisted thoracoscopic surgery versus thoracotomy for locally advanced lung cancer: a longitudinal cohort study. Ann Surg Oncol, 2021, 28(13): 8358-8371.
81. Wei X, Yu H, King-Kallimanis B, et al. Long-term function recovery following upper versus lower lobectomy for lung cancer: a multicenter longitudinal cohort study. Thorac Cancer, 2025, 16(1): e15505.
82. Avery KNL, Richards HS, Portal A, et al. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery. BMC Cancer, 2019, 19(1): 463.
83. O'Leary MC, Kwong E, Cox C, et al. Patient motivators of postoperative electronic patient-reported outcome symptom monitoring use in thoracic surgery patients: a qualitative study. J Patient Rep Outcomes, 2024, 8(1): 81.
84. Sewell M, Boerner T, Harrington C, et al. Remote symptom monitoring in thoracic surgery patients after discharge. Ann Surg, 2025, 281(6): 1063-1069.
85. Huang L, Kehlet H, Petersen RH. Reasons for staying in hospital after video-assisted thoracoscopic surgery lobectomy. BJS Open, 2022, 6(3): zrac050.
86. Shahoud J, Weksler B, Williams B, et al. Uniportal video-assisted lung resection versus robotic-assisted lung resection, is there a difference? J Thorac Dis, 2024, 16(11): 7539-7545.
87. Diaz-Gutierrez I, Menier CA, Savoie-White FH, et al. Uniportal vs. multiportal thoracoscopic segmentectomy: a North American study. J Thorac Dis, 2023, 15(2): 335-347.
88. 洪子強, 茍文曦, 逯英杰, 等. 達芬奇機器人手術與胸腔鏡手術治療非小細胞肺癌的短期療效及成本分析. 中國胸心血管外科臨床雜志, 2024, 31(7): 974-979.Hong ZQ, Gou WX, Lu YJ, et al. Short-term efficacy and cost analysis of Da Vinci robot-assisted thoracic surgery versus video-assisted thoracoscopic surgery for non-small cell lung cancer. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(7): 974-979.
89. 李田, 王高祥, 徐世斌, 等. 單孔胸腔鏡肺段切除術治療早期非小細胞肺癌的臨床研究. 安徽醫科大學學報, 2021, 56(11): 1816-1819.Li T, Wang GX, Xu SB, et al. Clinical study of uniportal thoracoscopic segmentectomy in the treatment of early non-small cell lung cancer. Acta Univ Med Anhui, 2021, 56(11): 1816-1819.
90. 王雅琴, 余鴻凡, 戴維, 等. 肺癌患者圍手術期自我報告疼痛評分與臨床記錄的一致性分析. 中國胸心血管外科臨床雜志, 2023, 30(11): 1545-1550.Wang YQ, Yu HF, Dai W, et al. Consistency analysis between self-reported pain scores and clinical records in lung cancer patients during perioperative period. Chin J Clin Thorac Cardiovasc Surg, 2023, 30(11): 1545-1550.
91. Wei X, Yu H, Dai W, et al. Discrepancy in the perception of symptoms among patients and healthcare providers after lung cancer surgery. Support Care Cancer, 2022, 30(2): 1169-1179.
92. 吳傳美, 周和玲, 蔣艷華, 等. 肺癌患者手術前自我報告癥狀負擔和生活質量的橫斷面調查. 腫瘤預防與治療, 2021, 34(3): 234-240.Wu CM, Zhou HL, Jiang YH, et al. A cross-sectional survey of self-reported symptom burden and quality of life in lung cancer patients before surgery. J Cancer Control Treat, 2021, 34(3): 234-240.
93. 周和玲, 蔣艷華, 吳傳美, 等. 肺癌病人術前苦惱現狀及其影響因素. 護理研究, 2021, 35(19): 3486-3489.Zhou HL, Jiang YH, Wu CM, et al. Current status and influencing factors of preoperative distress in lung cancer patients. Chin Nurs Res, 2021, 35(19): 3486-3489.
94. Mooney KH, Beck SL, Friedman RH, et al. Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial. Support Care Cancer, 2014, 22(9): 2343-2350.
95. Swarm RA, Paice JA, Anghelescu DL, et al. Adult cancer pain, version 3. 2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2019, 17(8): 977-1007.
96. Riba MB, Donovan KA, Andersen B, et al. Distress management, version 3. 2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2019, 17(10): 1229-1249.
97. Yu Q, Yu H, Xu W, et al. Shortness of breath on day 1 after surgery alerting the presence of early respiratory complications after surgery in lung cancer patients. Patient Prefer Adherence, 2022, 16: 709-722.
98. Kang D, Lei C, Zhang Y, et al. Shortness of breath on the day of discharge: an early alert for post-discharge complications in patients undergoing lung cancer surgery. J Cardiothorac Surg, 2024, 19(1): 398.
99. Maguire R, Fox PA, McCann L, et al. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer. BMJ Open, 2017, 7(5): e015016.
100. Pusic AL, Temple LK, Carter J, et al. A randomized controlled trial evaluating electronic outpatient symptom monitoring after ambulatory cancer surgery. Ann Surg, 2021, 274(3): 441-448.
101. Furlong E, Darley A, Fox P, et al. Adaptation and implementation of a mobile phone-based remote symptom monitoring system for people with cancer in Europe. JMIR Cancer, 2019, 5(1): e10813.
102. Richards HS, Blazeby JM, Portal A, et al. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery. BMC Cancer, 2020, 20(1): 543.
103. Maguire R, McCann L, Kotronoulas G, et al. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ, 2021, 374: n1647.
104. Stabile C, Temple LK, Ancker JS, et al. Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: a randomised controlled trial protocol. BMJ Open, 2019, 9(9): e030863.
105. Franzoi MA, Ferreira AR, Lemaire A, et al. Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium. Lancet Reg Health Eur, 2024, 44: 101005.
106. Li Y, Shen L, Ding J, et al. Derivation and validation of a nomogram model for pulmonary thromboembolism in patients undergoing lung cancer surgery. Transl Lung Cancer Res, 2021, 10(4): 1829-1840.
107. Zhou X, Lei C, Wei X, et al. Patient's experiences of coughing after lung cancer surgery: a multicenter qualitative study. Cancer Med, 2024, 13(2): e6993.
108. Song HJ, Seo HJ, Choi EJ, et al. Nursing care services to address unmet supportive care needs among cancer survivors: a systematic review. J Cancer Surviv, 2026, 20(2): 427-452.
109. Riba MB, Donovan KA, Ahmed K, et al. NCCN Guidelines? Insights: distress management, version 2. 2023. J Natl Compr Canc Netw, 2023, 21(5): 450-457.
110. Bower JE, Lacchetti C, Alici Y, et al. Management of fatigue in adult survivors of cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol, 2024, 42(20): 2456-2487.
111. 肺癌圍術期疼痛管理專家共識編寫組, 國家呼吸醫學中心(廣州), 全國疼痛診療研究中心, 國家疼痛專業醫療質量控制中心. 肺癌圍術期疼痛管理專家共識(2026版). 中國胸心血管外科臨床雜志, 2026, 33(5): 659-673.Expert Consensus Group on Perioperative Pain Management for Lung Cancer, National Center for Respiratory Medicine (Guangzhou), National Research Center for Pain Diagnosis and Treatment, National Medical Quality Control Center for Pain Specialty. Expert consensus on perioperative pain management for lung cancer (2026 edition). Chin J Clin Thorac Cardiovasc Surg, 2026, 33(5): 659-673.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Latest ArticlesExpert consensus on electronic patient-reported outcome-based symptom management for perioperative lung cancer patients (version 2026)

Abstract Full text Figures/Tables Video References Cited by

Format

Content